Microdosing Psilocybin: Side Effects, Risks, and How to Minimize Them
Microdosing psilocybin has an excellent safety profile compared to most pharmaceutical interventions for mental health. But "excellent safety profile" doesn't mean zero side effects or zero risk. This guide gives you an honest, evidence-based picture of what to expect — including who should not microdose.
Common Side Effects at Microdose Levels
Mild nausea: The most commonly reported side effect, typically occurring within the first 30–60 minutes after ingestion. Usually mild and passes quickly. Taking your dose with a light meal reduces nausea significantly. Ginger tea can help if nausea persists.
Increased alertness: Psilocybin has mild stimulant properties at low doses. Some people, particularly those with anxiety, experience this as a slight increase in heart rate or a feeling of being "too on." This typically resolves after the first few sessions as the body adjusts.
Headache: Reported by a minority of microdosers, usually mild. Staying well hydrated on dose days reduces incidence.
Sleep disturbance: Taking your dose too late in the day (after noon) can occasionally interfere with sleep in the first few weeks. Morning dosing eliminates this issue for most people.
Who Should Not Microdose
Psilocybin is contraindicated for people with a personal or family history of psychosis or schizophrenia — it can trigger psychotic episodes in predisposed individuals. People taking lithium should avoid psilocybin due to a risk of seizures. Those on MAOIs face a risk of serotonin syndrome. Pregnant or breastfeeding individuals should not use psilocybin.
Is Microdosing Addictive?
No. Psilocybin has no known addiction potential. Unlike alcohol, opioids, or stimulants, it does not activate the dopamine reward pathways associated with addictive substances. Tolerance builds quickly with daily use — which is exactly why all established protocols include off days.
Frequently Asked Questions
What are the side effects of microdosing psilocybin?
Common side effects include mild nausea, slight increase in alertness, and occasional headache. These are typically mild and decrease after the first few sessions.
Who should not microdose psilocybin?
People with a personal or family history of psychosis or schizophrenia, those on lithium or MAOIs, and pregnant or breastfeeding individuals should avoid psilocybin.
Is microdosing psilocybin addictive?
No. Psilocybin has no known addiction potential and does not activate dopamine reward pathways.